Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018)

Avanos Medical's Other Accumulated Expenses history spans 2 years, with the latest figure at $34.1 million for Q3 2018.

On a quarterly basis, Other Accumulated Expenses changed N/A to $34.1 million in Q3 2018 year-over-year; TTM through Sep 2018 was $34.1 million, a N/A change, with the full-year FY2017 number at $29.2 million, changed N/A from a year prior.
Other Accumulated Expenses hit $34.1 million in Q3 2018 for Avanos Medical, up from $29.2 million in the prior quarter.
Over the last five years, Other Accumulated Expenses for AVNS hit a ceiling of $34.1 million in Q3 2018 and a floor of $29.2 million in Q4 2017.